Bayer AG (OTC Pink - Current Information:BAYRY)
| 14.36 Delayed Data As of Jul 05 |  -0.66 / -4.39%Today’s Change | 12.45 Today|||52-Week Range 18.45 | +8.30% Year-to-Date |
Latest BAYRY News | Press Releases
| Regeneron (REGN) Eylea sBLA for Extended Regimen Accepted Jun 30 / Zacks.com - Paid Partner Content | Top Analyst Reports for UnitedHealth, Chevron & AstraZeneca Jun 24 / Zacks.com - Paid Partner Content |
| Investors Love Bayer, but the Courts Don’t – Buy, Sell, Hold? Jun 30 / StockNews.com - Paid Partner Content | Are You a Value Investor? This 1 Stock Could Be the Perfect Pick Jun 24 / Zacks.com - Paid Partner Content |
| The Zacks Analyst Blog Highlights UnitedHealth, Chevron, AstraZeneca, SAP and Bayer ktiengesellschaftt Jun 27 / Zacks.com - Paid Partner Content | Are You a Value Investor? This 1 Stock Could Be the Perfect Pick Jun 24 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 15.02 |
| Today’s open | 14.32 |
| Day’s range | 14.11 - 14.38 |
| Volume | 821,359 |
| Average volume (3 months) | 595,365 |
| Market cap | $59.0B |
Data as of 07/05/2022
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +6.45% |
| Earnings growth (next 5 years) | +3.50% |
| Revenue growth (last year) | +10.40% |
| P/E ratio | -- |
| Price/Sales | 1.01 |
| Price/Book | 1.57 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | August 4, 2022 |
| EPS forecast (this quarter) | $0.49 |
| Annual revenue (last year) | $52.1B |
| Annual profit (last year) | $1.2B |
| Net profit margin | 2.27% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Leverkusen, Nordrhein-westfalen |
Forecasts
Chart unavailable
